RADIESSE Injection in Perioral and Marionette Lines

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

July 11, 2020

Study Completion Date

July 11, 2020

Conditions
Skin Quality
Interventions
DEVICE

Radiesse (calcium hydroxylpatite)

"RADIESSE® injectable implant is a sterile, non-pyrogenic, semi-solid, cohesive implant, whose principle component is synthetic calcium hydroxylapatite (CaHA) suspended in a gel carrier of sterile water for injection, glycerin and sodium carboxymethylcellulose. RADIESSE injectable implant has a CaHA particle size range of 25-45 microns. RADIESSE is available in 1.5cc and 0.8cc pre-filled syringes.~RADIESSE injectable implant is indicated for subdermal implantation for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds and it is also intended for restoration and/or correction of the signs of facial fat loss (lipoatrophy)."

Trial Locations (1)

H3R 3A1

Erevna Innovations Inc, Montreal

Sponsors
All Listed Sponsors
lead

Erevna Innovations Inc.

OTHER